HP CELL VITARAN I

HP CELL VITARAN i is a polynucleotide-based biorevititaliser:
- Lifting: polynucleotides stimulate the proliferation of different types of skin cells, including fibroblasts, adipocytes and osteoblasts. The production of type I collagen and elastin is stimulated, which thickens and lifts the skin.
- Antioxidant action: the second mechanism concerns the elimination of free radicals and antioxidant activity. Polynucleotides support regeneration of UV-damaged skin.
- Moisturising: polynucleotides bind water and provide lasting iso-osmotic hydration of the intercellular matrix, making the skin firm and well moisturised.

- BR PHARM
- NAME: HP CELL VITARAN i
- COMPOSITION: Sodium Polynucleotide 20 mg/mL.
- PRESENTATION: 1 x 1 ml.
- INDICATIONS: Regenerates and tones the skin, particularly effective in the eye area.
- INJECTION DEPTH: It should be injected intradermally, at a specific depth depending on the area treated, with a volume of approximately 0.01-0.02 cm per area.
- NEEDLES: 1 x 33Gx4mm.
- DURATION: Results can last up to 9 months, depending on age, skin quality, genetics, lifestyle and sun exposure.
- USE: Strict medical use.

- Syringe: 1 x 1mL.
- Needles: 1 x 33Gx4mm.
- Each box contains one 1mL pre-filled disposable syringe of HP CELL VITARAN i, 1 sterile, single-use 33Gx4mm needle, reserved for injection of HP CELL VITARAN i.

Face, neck, décolleté, eye contour and hands.

Sodium Polynucleotide 20 mg/mL.

The product is intended exclusively for qualified professionals. Avoid use in case of known allergy to the components of the preparation, inflamed or injured skin, pregnancy or lactation, uncontrolled diabetes, coagulation disorders or taking anticoagulant drugs. Caution should be exercised in case of sensitive skin or skin at risk of fibrosis. Always follow the manufacturer's official protocol and the doctor's instructions.

HP CELL VITARAN i is contraindicated in the following cases:
- Allergy to the components used during treatment.
- Pregnancy and lactation.
- Uncontrolled diabetes.
- Active skin infections or lesions in the area to be treated.
- Sensitive skin or skin at risk of fibrosis, e.g. very vascularised skin or skin that does not tolerate injections well.
- History of malignant tumours.
- Taking anticoagulant drugs or drugs that interfere with blood clotting.

Anti-ageing therapy, skin revitalisation, loss of tone and firmness, lifting effect, treatment of photo-ageing, dry, dehydrated and dull skin, smokers' skin, reduction of scars and stretch marks, including acne scars.